• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非瓣膜性心房颤动患者左心耳血栓形成的危险因素

Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation.

作者信息

Liu Yaowu, Zhu Didi, Xiao Yunyun, Zhu Yeqian, Zhou Qianxing, Ren Liqun, Chen Long

机构信息

Department of Cardiology, Zhongda Hospital of Southeast University, Nanjing, 210009, China.

Department of Geriatrics, Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing, 210008, China.

出版信息

Open Med (Wars). 2021 Mar 3;16(1):361-366. doi: 10.1515/med-2021-0009. eCollection 2021.

DOI:10.1515/med-2021-0009
PMID:33869773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8024551/
Abstract

OBJECTIVE

To investigate the risk factors of left atrial appendage thrombus (LAAT) in patients with non-valvular atrial fibrillation (AF).

METHODS

We collected the clinical data of patients with non-valvular AF who underwent transesophageal echocardiography (TEE) at the Zhongda Hospital of Southeast University between January 2016 and June 2019. The patients were divided into two groups, LAAT and non-LAAT. We performed comparative analysis, receiver operating characteristic (ROC) curve analysis and logistic regression analysis to estimate the risk factors of LAAT.

RESULTS

A total of 442 patients with non-valvular AF were enrolled in the study. LAAT was detected by TEE in 20 cases (4.7%). Compared with patients without LAAT, patients with LAAT had higher CHADS-VASc scores (3 vs 2, = 0.001), higher values of D-dimer (180.0 vs 90.0 μg/L, = 0.003), larger LA anteroposterior diameters (50.5 vs 41.0 mm, < 0.001) and higher ratios of non-paroxysmal AF (85.0% vs 23.6%, < 0.001). ROC curve analysis revealed that the cutoff value of LA anteroposterior diameter was 49.5 mm. After adjusting for other confounders, logistic regression analysis showed that enlarged LA (anteroposterior diameter ≥49.5 mm) and non-paroxysmal AF were independently associated with higher risks of LAAT (OR = 7.28, 95% CI: 2.36-22.47; OR = 8.89, 95% CI: 2.33-33.99, respectively). The proportions of LAAT in patients with larger LA (anteroposterior diameter ≥49.5 mm), non-paroxysmal AF and both larger LA and non-paroxysmal AF were 30% (12/40), 15.2% (17/112) and 39.1% (9/23), respectively.

CONCLUSION

Enlarged LA (anteroposterior diameter ≥49.5 mm) and non-paroxysmal AF were independent risk factors of LAAT in non-valvular AF patients.

摘要

目的

探讨非瓣膜性心房颤动(AF)患者左心耳血栓(LAAT)的危险因素。

方法

收集2016年1月至2019年6月在东南大学附属中大医院接受经食管超声心动图(TEE)检查的非瓣膜性AF患者的临床资料。将患者分为两组,即LAAT组和非LAAT组。我们进行了对比分析、受试者工作特征(ROC)曲线分析和逻辑回归分析,以评估LAAT的危险因素。

结果

本研究共纳入442例非瓣膜性AF患者。TEE检测到20例(4.7%)LAAT。与无LAAT的患者相比,LAAT患者的CHADS-VASc评分更高(3分对2分,P = 0.001),D-二聚体值更高(180.0对90.0μg/L,P = 0.003),左房前后径更大(50.5对41.0mm,P < 0.001),非阵发性AF的比例更高(85.0%对23.6%,P < 0.001)。ROC曲线分析显示,左房前后径的截断值为49.5mm。在调整其他混杂因素后,逻辑回归分析显示,左房扩大(前后径≥49.5mm)和非阵发性AF与LAAT的较高风险独立相关(OR分别为7.28,95%CI:2.36 - 22.47;OR为8.89,95%CI:2.33 - 33.99)。左房扩大(前后径≥49.5mm)、非阵发性AF以及左房扩大合并非阵发性AF的患者中LAAT的比例分别为30%(12/40)、15.2%(17/112)和39.1%(9/23)。

结论

左房扩大(前后径≥49.5mm)和非阵发性AF是非瓣膜性AF患者LAAT独立的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b4f/8024551/f2fcedfbd154/j_med-2021-0009-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b4f/8024551/71c0117a1cf4/j_med-2021-0009-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b4f/8024551/f2fcedfbd154/j_med-2021-0009-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b4f/8024551/71c0117a1cf4/j_med-2021-0009-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b4f/8024551/f2fcedfbd154/j_med-2021-0009-fig002.jpg

相似文献

1
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation.非瓣膜性心房颤动患者左心耳血栓形成的危险因素
Open Med (Wars). 2021 Mar 3;16(1):361-366. doi: 10.1515/med-2021-0009. eCollection 2021.
2
Predictive value of left atrial appendage lobes on left atrial thrombus or spontaneous echo contrast in patients with non-valvular atrial fibrillation.非瓣膜性心房颤动患者左心耳叶对左心房血栓或自发显影的预测价值
BMC Cardiovasc Disord. 2018 Jul 31;18(1):153. doi: 10.1186/s12872-018-0889-y.
3
Development and validation of a nomogram superior to CHADS and CHADS-VASc models for predicting left atrial appendage dense spontaneous echo contrast/left atrial appendage thrombus.一种优于CHADS和CHADS-VASc模型的列线图的开发与验证,用于预测左心耳致密自发回声增强/左心耳血栓。
J Thorac Dis. 2024 Mar 29;16(3):2102-2114. doi: 10.21037/jtd-24-288. Epub 2024 Mar 27.
4
Left Atrial Appendage Thrombus Formation Despite Continuous Non-Vitamin K Antagonist Oral Anticoagulant Therapy in Atrial Fibrillation Patients Undergoing Electrical Cardioversion or Catheter Ablation: A Comparison of Dabigatran and Rivaroxaban.房颤患者在接受电复律或导管消融术时,尽管持续使用非维生素K拮抗剂口服抗凝药治疗,仍发生左心耳血栓形成:达比加群与利伐沙班的比较
Cardiol Res Pract. 2020 Sep 17;2020:1206402. doi: 10.1155/2020/1206402. eCollection 2020.
5
A new risk model of assessing left atrial appendage thrombus in patients with atrial fibrillation - Using multiple clinical and transesophageal echocardiography parameters.一种评估心房颤动患者左心耳血栓的新风险模型——利用多种临床和经食管超声心动图参数
Int J Cardiol. 2020 Sep 1;314:60-63. doi: 10.1016/j.ijcard.2020.04.039. Epub 2020 Apr 17.
6
Real-Time Pathophysiologic Correlates of Left Atrial Appendage Thrombus in Patients Who Underwent Transesophageal-Guided Electrical Cardioversion for Atrial Fibrillation.接受经食管引导的房颤电复律患者左心耳血栓的实时病理生理相关性
Am J Cardiol. 2018 Jun 15;121(12):1540-1547. doi: 10.1016/j.amjcard.2018.02.044. Epub 2018 Mar 13.
7
Thrombus in the left atrial appendage in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants in clinical practice-A multicenter registry.临床实践中接受非维生素K拮抗剂口服抗凝剂治疗的房颤患者左心耳血栓——一项多中心注册研究
J Cardiovasc Electrophysiol. 2020 Aug;31(8):2005-2012. doi: 10.1111/jce.14589. Epub 2020 Jun 11.
8
Risk stratification of patients with left atrial appendage thrombus prior to catheter ablation of atrial fibrillation: An approach towards an individualized use of transesophageal echocardiography.心房颤动导管消融术前左心耳血栓患者的风险分层:一种个体化使用经食管超声心动图的方法。
J Cardiovasc Electrophysiol. 2017 Oct;28(10):1127-1136. doi: 10.1111/jce.13279. Epub 2017 Jul 26.
9
Incremental diagnostic role of left atrial strain analysis in thrombotic risk assessment of nonvalvular atrial fibrillation patients planned for electrical cardioversion.左房应变分析在计划电复律的非瓣膜性心房颤动患者血栓风险评估中的增量诊断作用。
Int J Cardiovasc Imaging. 2021 May;37(5):1539-1550. doi: 10.1007/s10554-020-02127-6. Epub 2021 Jan 3.
10
Renin-angiotensin system inhibition is associated with reduced risk of left atrial appendage thrombosis formation in patients with atrial fibrillation.肾素-血管紧张素系统抑制与房颤患者左心耳血栓形成风险降低相关。
Cardiol J. 2018;25(5):611-620. doi: 10.5603/CJ.a2017.0112. Epub 2017 Oct 5.

引用本文的文献

1
Incidence and predictors of left atrial thrombus in patients with atrial fibrillation under anticoagulation therapy.抗凝治疗的心房颤动患者左心房血栓的发生率及预测因素。
Clin Res Cardiol. 2024 Aug;113(8):1242-1250. doi: 10.1007/s00392-024-02422-5. Epub 2024 Mar 6.
2
Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation.射血分数保留的心力衰竭:解释心房颤动临床意义的另一种范式。
Heart Rhythm O2. 2021 Dec 17;2(6Part B):771-783. doi: 10.1016/j.hroo.2021.09.015. eCollection 2021 Dec.

本文引用的文献

1
Left atrial appendage thrombus detected by transesophageal examination with linear endoscopic ultrasound.经食管线性内镜超声检查发现左心耳血栓。
Clin Case Rep. 2019 May 28;7(7):1327-1330. doi: 10.1002/ccr3.2223. eCollection 2019 Jul.
2
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.2017年心房颤动导管消融与外科消融治疗专家共识声明:由心律学会(HRS)、欧洲心律协会(EHRA)、欧洲心血管病预防与康复协会(ECAS)、亚太心律学会(APHRS)及拉丁美洲心脏学会(SOLAECE)联合发布
Heart Rhythm. 2017 Oct;14(10):e275-e444. doi: 10.1016/j.hrthm.2017.05.012. Epub 2017 May 12.
3
CHADS-VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean Nationwide Sample Cohort Study.
亚洲房颤患者卒中的CHADS-VASc评分(充血性心力衰竭、高血压、年龄≥75岁[加倍]、糖尿病、既往卒中或短暂性脑缺血发作[加倍]、血管疾病、年龄65 - 74岁、女性):一项韩国全国性样本队列研究。
Stroke. 2017 Jun;48(6):1524-1530. doi: 10.1161/STROKEAHA.117.016926. Epub 2017 Apr 28.
4
Atrial Fibrillation.心房颤动。
Ann Intern Med. 2017 Mar 7;166(5):ITC33-ITC48. doi: 10.7326/AITC201703070.
5
Meta-analysis of ATRIA versus CHADS-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation.用于预测心房颤动患者中风和血栓栓塞的 ATRIA 与 CHADS-VASc 的荟萃分析。
Int J Cardiol. 2017 Jan 15;227:436-442. doi: 10.1016/j.ijcard.2016.11.015. Epub 2016 Nov 9.
6
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.2016年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动管理指南。
Eur Heart J. 2016 Oct 7;37(38):2893-2962. doi: 10.1093/eurheartj/ehw210. Epub 2016 Aug 27.
7
Atrial fibrillation and silent stroke: links, risks, and challenges.心房颤动与无症状性卒中:联系、风险及挑战。
Vasc Health Risk Manag. 2016 Mar 7;12:65-74. doi: 10.2147/VHRM.S81807. eCollection 2016.
8
Left atrial appendage morphology assessment for risk stratification of embolic stroke in patients with atrial fibrillation: A meta-analysis.房颤患者栓塞性卒中风险分层的左心耳形态学评估:一项荟萃分析。
Heart Rhythm. 2016 Jul;13(7):1402-9. doi: 10.1016/j.hrthm.2016.03.042. Epub 2016 Mar 22.
9
Comparison of the ATRIA, CHADS2, and CHA2DS2-VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation.比较 ATRIA、CHADS2 和 CHA2DS2-VASc 卒中风险评分在预测大型瑞典房颤患者缺血性卒中中的作用。
Eur Heart J. 2016 Nov 7;37(42):3203-3210. doi: 10.1093/eurheartj/ehw077. Epub 2016 Mar 3.
10
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation.ABC(年龄、生物标志物、临床病史)卒中风险评分:一种基于生物标志物的房颤卒中预测风险评分。
Eur Heart J. 2016 May 21;37(20):1582-90. doi: 10.1093/eurheartj/ehw054. Epub 2016 Feb 25.